Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4002 Basel, Switzerland.
Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
Cell Rep. 2022 Oct 18;41(3):111489. doi: 10.1016/j.celrep.2022.111489.
Signaling through innate immune receptors such as the Toll-like receptor (TLR)/interleukin-1 receptor (IL-1R) superfamily proceeds via the assembly of large membrane-proximal complexes or "signalosomes." Although structurally distinct, the IL-17 receptor family triggers cellular responses that are typical of innate immune receptors. The IL-17RA receptor subunit is shared by several members of the IL-17 family. Using a combination of crystallographic, biophysical, and mutational studies, we show that IL-17A, IL-17F, and IL-17A/F induce IL-17RA dimerization. X-ray analysis of the heteromeric IL-17A complex with the extracellular domains of the IL-17RA and IL-17RC receptors reveals that cytokine-induced IL-17RA dimerization leads to the formation of a 2:2:2 hexameric signaling assembly. Furthermore, we demonstrate that the formation of the IL-17 signalosome potentiates IL-17-induced IL-36γ and CXCL1 mRNA expression in human keratinocytes, compared with a dimerization-defective IL-17RA variant.
先天免疫受体(如 Toll 样受体(TLR)/白细胞介素-1 受体(IL-1R)超家族)通过组装大型膜近端复合物或“信号体”来进行信号转导。尽管结构不同,但 IL-17 受体家族引发的细胞反应与先天免疫受体典型的反应相似。IL-17RA 受体亚基被 IL-17 家族的几个成员共享。我们通过晶体学、生物物理学和突变研究的组合,表明 IL-17A、IL-17F 和 IL-17A/F 诱导 IL-17RA 二聚化。IL-17RA 和 IL-17RC 受体的细胞外结构域与异源二聚体 IL-17A 复合物的 X 射线分析表明,细胞因子诱导的 IL-17RA 二聚化导致形成 2:2:2 六聚体信号转导组装体。此外,我们证明与二聚化缺陷的 IL-17RA 变体相比,IL-17 信号体的形成增强了人角质形成细胞中 IL-17 诱导的 IL-36γ 和 CXCL1 mRNA 的表达。